163 related articles for article (PubMed ID: 24790003)
1. Effects of pH and buffer concentration on the thermal stability of etanercept using DSC and DLS.
Kim NA; An IB; Lim DG; Lim JY; Lee SY; Shim WS; Kang NG; Jeong SH
Biol Pharm Bull; 2014; 37(5):808-16. PubMed ID: 24790003
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment.
Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of etanercept stability as exposed to various sugars with biophysical assessment.
Lim DG; Kim NA; Lim JY; Kim KH; Hada S; Jeong SH
Int J Pharm; 2014 Dec; 476(1-2):50-9. PubMed ID: 25269011
[TBL] [Abstract][Full Text] [Related]
4. Fundamental analysis of recombinant human epidermal growth factor in solution with biophysical methods.
Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
Drug Dev Ind Pharm; 2015 Feb; 41(2):300-6. PubMed ID: 24502269
[TBL] [Abstract][Full Text] [Related]
5. Biophysical evaluation of hybrid Fc fusion protein of hGH to achieve basal buffer system.
Kim NA; An IB; Lim HS; Yang SI; Jeong SH
Int J Pharm; 2016 Nov; 513(1-2):421-430. PubMed ID: 27659863
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylated-L-arginine (NALA) is an enhanced protein aggregation suppressor under interfacial stresses and elevated temperature for protein liquid formulations.
Kim NA; Hada S; Jeong SH
Int J Biol Macromol; 2021 Jan; 166():654-664. PubMed ID: 33137385
[TBL] [Abstract][Full Text] [Related]
8. Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches.
Kim NA; Song K; Lim DG; Hada S; Shin YK; Shin S; Jeong SH
Eur J Pharm Sci; 2015 Oct; 78():177-89. PubMed ID: 26215462
[TBL] [Abstract][Full Text] [Related]
9. [Non-native conformational states of immunoglobulins: thermodynamic and functional analysis of rabbit IgG].
Vlasov AP; Kravchuk ZI; Martsev SP
Biokhimiia; 1996 Feb; 61(2):212-35. PubMed ID: 8717493
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of etanercept degradation under oxidative stress and potential protective effects of various amino acids.
Lim JY; Kim NA; Lim DG; Kim KH; Hada S; Jeong SH
Int J Pharm; 2015 Aug; 492(1-2):127-36. PubMed ID: 26187168
[TBL] [Abstract][Full Text] [Related]
11. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
Sahin E; Grillo AO; Perkins MD; Roberts CJ
J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
[TBL] [Abstract][Full Text] [Related]
13. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
[TBL] [Abstract][Full Text] [Related]
14. Relation of Colloidal and Conformational Stabilities to Aggregate Formation in a Monoclonal Antibody.
Oyama H; Koga H; Tadokoro T; Maenaka K; Shiota A; Yokoyama M; Noda M; Torisu T; Uchiyama S
J Pharm Sci; 2020 Jan; 109(1):308-315. PubMed ID: 31669120
[TBL] [Abstract][Full Text] [Related]
15. Optimization of protein solution by a novel experimental design method using thermodynamic properties.
Kim NA; An IB; Lee SY; Park ES; Jeong SH
Arch Pharm Res; 2012 Sep; 35(9):1609-19. PubMed ID: 23054718
[TBL] [Abstract][Full Text] [Related]
16. Arginine as a protein stabilizer and destabilizer in liquid formulations.
Kim NA; Hada S; Thapa R; Jeong SH
Int J Pharm; 2016 Nov; 513(1-2):26-37. PubMed ID: 27596112
[TBL] [Abstract][Full Text] [Related]
17. Comparison of analytical methods to detect instability of etanercept during thermal stress testing.
Maarschalkerweerd Av; Wolbink GJ; Stapel SO; Jiskoot W; Hawe A
Eur J Pharm Biopharm; 2011 Jun; 78(2):213-21. PubMed ID: 21272639
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
[TBL] [Abstract][Full Text] [Related]
19. High throughput thermostability screening of monoclonal antibody formulations.
He F; Hogan S; Latypov RF; Narhi LO; Razinkov VI
J Pharm Sci; 2010 Apr; 99(4):1707-20. PubMed ID: 19780136
[TBL] [Abstract][Full Text] [Related]
20. Conformation, pH-induced conformational changes, and thermal unfolding of anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab and Fc fragments.
Welfle K; Misselwitz R; Hausdorf G; Höhne W; Welfle H
Biochim Biophys Acta; 1999 Apr; 1431(1):120-31. PubMed ID: 10209285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
